Novartis shines in plant power

Novartis (NYSE: NVS) has dedicated a 1-megawatt solar array attached to its Vacaville, CA, biopharmaceutical site. The company expects to meet 20 percent of the plant's power needs from the $7 million system, whose 4100 solar panels cover five acres. Novartis has solar systems at five other sites. Article

Suggested Articles

The FDA asked five drugmakers to pull their version of extended-release metformin off U.S. shelves after finding carcinogen contamination.

The FDA backtracked on its earlier testing and found NDMA contamination in the extended release formulation of certain generic versions of metformin.

GSK has formed several collaborations across the globe that will use its AS03 adjuvant to develop vaccines against the novel coronavirus.